Closing prices at the end of each trading day, from 15 May 2025. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.
| FY2024 | FY2025 | |
|---|---|---|
| Revenue | n/a | 0.1 |
| Growth | ||
| Net income | −4.5 | −12.8 |
| Growth | ||
| EPS, diluted | −0.16 | −0.40 |
| Growth |
| FY2024 | FY2025 | |
|---|---|---|
| Net margin | n/a | −11,325.7% |
| Free cash flow margin | n/a | −7,725.0% |
| FY2024 | FY2025 | |
|---|---|---|
| Operating cash flow | −2.3 | −8.3 |
| Capital expenditure | −0.0 | −0.5 |
| Free cash flow | −2.3 | −8.7 |
| Growth |
| FY2024 | FY2025 | |
|---|---|---|
| Cash | 0.1 | 2.1 |
| Shareholders’ equity | −1.0 | 2.5 |
In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.
| Fiscal year | FY2024 31 Dec 2024 | FY2025 31 Dec 2025 |
|---|---|---|
| Operations | ||
| −2.3 | −8.3 | |
| Growth | ||
| Investment | ||
| −0.0 | −0.5 | |
| calc | −2.3 | −8.7 |
| Growth | ||
| calc | −0.08 | −0.27 |
| −0.1 | −0.4 | |
| Financing | ||
| 2.2 | 10.6 | |
Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.